These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 15511402)

  • 1. [Pharmacoeconomic analysis of patients with acute exacerbation of chronic bronchitis treated with telithromycin or cefuroxime-axetil].
    Rubio-Terrés C; Cots JM; Domínguez-Gil A; Herreras A; Sánchez Gascón F; Chang J; Trilla A
    Rev Clin Esp; 2004 Nov; 204(11):567-73. PubMed ID: 15511402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral telithromycin 800 mg once daily for 5 days versus cefuroxime axetil 500 mg twice daily for 10 days in adults with acute exacerbations of chronic bronchitis.
    Zervos MJ; Heyder AM; Leroy B
    J Int Med Res; 2003; 31(3):157-69. PubMed ID: 12870368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Open-label, randomized comparison of the efficacy and tolerability of clarithromycin, levofloxacin, and cefuroxime axetil in the treatment of adults with acute bacterial exacerbations of chronic bronchitis.
    Weiss LR
    Clin Ther; 2002 Sep; 24(9):1414-25. PubMed ID: 12380633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pharmacoeconomic analysis of community-acquired pneumonia treatment with telithromycin or clarithromycin].
    Rubio-Terrés C; Cots JM; Domínguez-Gil A; Herreras A; Sánchez Gascón F; Chang J; Trilla A
    Rev Esp Quimioter; 2003 Sep; 16(3):295-303. PubMed ID: 14702121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of the efficacy of telithromycin versus cefuroxime axetil in the treatment of acute bacterial maxillary sinusitis.
    Buchanan PP; Stephens TA; Leroy B
    Am J Rhinol; 2003; 17(6):369-77. PubMed ID: 14750614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and bacteriological efficacy of 5-day telithromycin in acute maxillary sinusitis: a pooled analysis.
    Roos K; Tellier G; Baz M; Leroy B; Rangaraju M
    J Infect; 2005 Apr; 50(3):210-20. PubMed ID: 15780415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Telithromycin for the treatment of acute exacerbations of chronic bronchitis.
    Fogarty C; Zervos M; Tellier G; Aubier M; Rangaraju M; Nusrat R
    Int J Clin Pract; 2005 Mar; 59(3):296-305. PubMed ID: 15857326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and bacteriological efficacy in treatment of acute exacerbations of chronic bronchitis with cefditoren-pivoxil versus cefuroxime-axetil.
    Alvarez-Sala JL; Kardos P; Martínez-Beltrán J; Coronel P; Aguilar L
    Antimicrob Agents Chemother; 2006 May; 50(5):1762-7. PubMed ID: 16641447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Telithromycin for the treatment of acute bacterial maxillary sinusitis: a review of a new antibacterial agent.
    Tellier G; Brunton SA; Nusrat R
    South Med J; 2005 Sep; 98(9):863-8. PubMed ID: 16217977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized, double-blind study of ciprofloxacin and cefuroxime axetil for treatment of acute bacterial exacerbations of chronic bronchitis. The Bronchitis Study Group.
    Chodosh S; McCarty J; Farkas S; Drehobl M; Tosiello R; Shan M; Aneiro L; Kowalsky S
    Clin Infect Dis; 1998 Oct; 27(4):722-9. PubMed ID: 9798024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short-term and long-term outcomes of moxifloxacin compared to standard antibiotic treatment in acute exacerbations of chronic bronchitis.
    Wilson R; Allegra L; Huchon G; Izquierdo JL; Jones P; Schaberg T; Sagnier PP;
    Chest; 2004 Mar; 125(3):953-64. PubMed ID: 15006954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Levofloxacin versus cefuroxime axetil in the treatment of acute exacerbation of chronic bronchitis: results of a randomized, double-blind study.
    Shah PM; Maesen FP; Dolmann A; Vetter N; Fiss E; Wesch R
    J Antimicrob Chemother; 1999 Apr; 43(4):529-39. PubMed ID: 10350383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bacteriological efficacy of 5-day therapy with telithromycin in acute maxillary sinusitis.
    Buchanan P; Roos K; Tellier G; Rangaraju M; Leroy B
    Int J Antimicrob Agents; 2005 Mar; 25(3):237-46. PubMed ID: 15737519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Telithromycin.
    Wellington K; Noble S
    Drugs; 2004; 64(15):1683-94; discussion 1695-6. PubMed ID: 15257629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral gemifloxacin once daily for 5 days compared with sequential therapy with i.v. ceftriaxone/oral cefuroxime (maximum of 10 days) in the treatment of hospitalized patients with acute exacerbations of chronic bronchitis.
    Wilson R; Langan C; Ball P; Bateman K; Pypstra R;
    Respir Med; 2003 Mar; 97(3):242-9. PubMed ID: 12645831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Five-day telithromycin once daily is as effective as 10-day clarithromycin twice daily for the treatment of acute exacerbations of chronic bronchitis and is associated with reduced health-care resource utilization.
    Fogarty C; de Wet R; Mandell L; Chang J; Rangaraju M; Nusrat R
    Chest; 2005 Oct; 128(4):1980-8. PubMed ID: 16236845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative study of cefaclor AF vs. cefuroxime axetil in acute exacerbations of chronic bronchitis.
    Haczyński J; Chyczewska E; Grzelewska-Rzymowska I; Malolepszy J; Marcinkowska-Suchowierska E; Milanowski J; Oklek K; Płusa T; Słominski J; Szmygin K; Rek M
    Med Sci Monit; 2002 Jan; 8(1):PI1-7. PubMed ID: 11782685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bacteriological eradication of Streptococcus pneumoniae from patients with acute exacerbations of chronic bronchitis: cefuroxime axetil versus cefixime.
    Zuck P; Petitpretz P; Geslin P; Rio Y; Leblanc F
    Int J Clin Pract; 1999 Sep; 53(6):437-43. PubMed ID: 10622071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment of acute exacerbations of chronic bronchitis. Multicenter, randomized comparative study of cefuroxime axetil versus ofloxacin].
    Kleckow M
    Fortschr Med; 1991 Jul; 109(22):450-4. PubMed ID: 1937326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibiotic activity of telithromycin and comparators against bacterial pathogens isolated from 3,043 patients with acute exacerbation of chronic bronchitis.
    Sethi S; Anzueto A; Farrell DJ
    Ann Clin Microbiol Antimicrob; 2005 Mar; 4():5. PubMed ID: 15755326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.